Invention Grant
- Patent Title: Antibodies with reduced binding to process impurities
-
Application No.: US16339027Application Date: 2017-10-03
-
Publication No.: US11254753B2Publication Date: 2022-02-22
- Inventor: Hella Bosteels , Shugui Chen , Kayeleigh Farrow , Richard Kucia-Tran , William John Kenneth Lewis , Andrew S. Thomson , Mark Uden
- Applicant: GlaxoSmithKline Intellectual Property Development Limited
- Applicant Address: GB Middlesex
- Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee: GlaxoSmithKline Intellectual Property Development Limited
- Current Assignee Address: GB Middlesex
- Agent Craig T. Ajmo; J. Scott Young
- International Application: PCT/EP2017/075038 WO 20171003
- International Announcement: WO2018/065389 WO 20180412
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/00

Abstract:
The present invention relates to variant antibodies and methods of generating said antibodies with a reduced level of binding to process impurities. In particular, the invention describes variant IgG4 antibodies which have been modified in the heavy chain constant region at any one or a combination of amino acids in the region between Kabat residues 203 and 256, wherein the variant IgG4 antibody has a reduced level of binding to host cell protein (HCP), compared to an unmodified IgG4 antibody. The invention also relates to compositions comprising said variant IgG4 antibodies.
Public/Granted literature
- US20190225708A1 ANTIBODIES WITH REDUCED BINDING TO PROCESS IMPURITIES Public/Granted day:2019-07-25
Information query